Related to Danish Consortium Gets DKK24M Funding to Identify Drugs against Epigenetic Factors

• Scientists Able to Reprogram Human Embryos Using Human Eggs but Not Animal Eggs
  
• Epigenomics Grants Predictive Biosciences Rights to Use a Biomarker in a Prostate Cancer Test
  
• Scientists Uncover Tumor Suppressor in Colorectal Cancer
  
• DxS and Epigenomics Cross-License Technologies for DNA Methylation In Vitro Diagnostics
  
• Gene Involved in Energy Consumption Is Epigenetically Modified in Type 2 Diabetics
  
• Einstein Obtains $3.5M to Study Epigenomics of Abnormal Fetal Growth and Chronic Kidney Disease
  
• Researchers Explain How Tobacco Carcinogen NNK Triggers Lung Tumors
  
• Investigators Come Up with Virus-Free Technique to Make Stem Cells Pluripotent
  
• Researchers Uncover Mechanism of Tobacco Carcinogen
  
• Life Technologies Introduces Nanocrystal-Based Single Molecule Sequencing Technology
  
• Broad Institute Buys Another 30 Genome Analyzers from Illumina
  
• Researchers Find Hypermethylation in Glioblastoma Indicates Earlier Disease Onset but Improved Outcomes
  
• Ghent University to Leverage Roche´s LightCycler® 1536 Instrument for Cancer Research
  
• Exact Sciences Obtains OncoMethylome Biomarkers for Colorectal Cancer Test
  
• New England Biolabs Receives $1.22M to Develop Enzymatic Reagents for Epigenetic Studies
  
• Clinical Genomics Snags Colorectal Cancer Biomarkers from Garvan Institute
  
• SAFC Adds 50,000 Square Feet to Jerusalem Site to Bump Up Fermentation Capabilities
  
• Scientists Report that Methylation Chaos in Cancer Contributes to Cell Adaptability
  
• Merck & Co. and Simcere Form JV to Expand Access to Drugs in China
  
• Qiagen Acquires License to Orion’s MethylScreen Platform for Use in Epigenetics Kits